| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;92:555-561.)
© 1995 American Heart Association, Inc.
Articles |
Early Left Ventricular Dysfunction Elicits Activation of Sympathetic Drive and Attenuation of Parasympathetic Tone in the Paced Canine Model of Congestive Heart Failure
Presented in part at the 65th Scientific Sessions of the American Heart Association, New Orleans, La, November 16-19, 1992.
From the Department of Medicine, Division of Cardiology, the Ohio State University, Columbus.
Correspondence to Dr Gregory M. Eaton, Department of Internal Medicine, Division of Cardiology, The Ohio State University, 1654 Upham Dr, 631 Means Hall, Columbus, OH 43210.
Background Although autonomic imbalance is known to be characteristic of patients with clinically overt symptomatic congestive heart failure, it is currently unknown whether this autonomic response arises early in the course of left ventricular dysfunction or is restricted to the later stages of circulatory failure.
Methods and Results This investigation utilized the technique of spectral analysis of heart rate variability in a paced canine model of congestive heart failure that permits an examination of autonomic activity at the earliest stages of ventricular dysfunction to determine whether early systolic dysfunction in congestive heart failure is characterized by autonomic imbalance, which may contribute to subsequent myocardial and vascular dysfunction. The results indicate that autonomic imbalance as reflected in an abnormal pattern of heart rate variability evolves early in the course of ventricular systolic dysfunction consisting of both a significant increase in sympathetically influenced low-frequency heart rate variability and a significant reduction of parasympathetically mediated high-frequency variability. This was quantified by a marked and significant increase in the area under the low-frequency region from 0.053±0.037 (beats per minute)2 at baseline to 0.182±0.143 (beats per minute)2 at 48 hours to 0.253± 0.202 (beats per minute)2 after 7 days of pacing (ANOVA, P<.04). The area under the high-frequency region of the curve showed a decrease from a baseline value of 0.945±0.037 (beats per minute)2 to 0.811±0.152 (beats per minute)2 at 48 hours to 0.733±0.197 (beats per minute)2 after 7 days of pacing (ANOVA, P<.03). This resulted in a shift in autonomic balance away from parasympathetic tone and toward augmented sympathetic drive as reflected by the ratio of high- to low-frequency areas from a baseline value of 15.2±9.6 to 10.1±6.89 at 48 hours and 0.004±0.001 at 7 days (ANOVA, P<.01).
Conclusions The results indicate that autonomic imbalance as reflected in an abnormal pattern of heart rate variability evolves early in the course of ventricular systolic dysfunction consisting of both a significant increase in sympathetically influenced low-frequency heart rate variability and a significant reduction of parasympathetically mediated high-frequency variability. The early appearance of these autonomic abnormalities suggests that autonomic imbalance plays a significant role in promoting the progression of circulatory failure.
Key Words: heart failure • heart rate • spectrum analysis
This article has been cited by other articles:
 |
|
 |
|
  M. Henze, D. Hart, A. Samarel, J. Barakat, L. Eckert, and K. Scrogin Persistent alterations in heart rate variability, baroreflex sensitivity, and anxiety-like behaviors during development of heart failure in the rat Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H29 - H38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. T. Leung, M. E. Bowman, T. M. Diep, G. Lorenzi-Filho, J. S. Floras, and T. D. Bradley Influence of Cheyne-Stokes respiration on ventricular response to atrial fibrillation in heart failure J Appl Physiol, November 1, 2005; 99(5): 1689 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Motte, M. Mathieu, S. Brimioulle, A. Pensis, L. Ray, J.-M. Ketelslegers, N. Montano, R. Naeije, P. van de Borne, and K. M. Entee Respiratory-related heart rate variability in progressive experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1729 - H1735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Okoshi, M. Nakayama, X. Yan, M. P. Okoshi, A. J.T. Schuldt, M. A. Marchionni, and B. H. Lorell Neuregulins Regulate Cardiac Parasympathetic Activity: Muscarinic Modulation of {beta}-Adrenergic Activity in Myocytes From Mice With Neuregulin-1 Gene Deletion Circulation, August 10, 2004; 110(6): 713 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Gronefeld and S. H. Hohnloser Heart Failure Complicated by Atrial Fibrillation: Mechanistic, Prognostic, and Therapeutic Implications Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 107 - 113. [Abstract] [PDF]
|
|
|
|
 |
|
 M.T. Meinardi, D.J. van Veldhuisen, J.A. Gietema, W.V. Dolsma, F. Boomsma, M.P. van den Berg, C. Volkers, J. Haaksma, E.G.E. de Vries, D.Th. Sleijfer, et al. Prospective Evaluation of Early Cardiac Damage Induced by Epirubicin-Containing Adjuvant Chemotherapy and Locoregional Radiotherapy in Breast Cancer Patients J. Clin. Oncol., May 15, 2001; 19(10): 2746 - 2753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Notarius and J. S. Floras Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure Europace, January 1, 2001; 3(1): 29 - 38. [Abstract] [PDF]
|
|
|
|
 |
|
 G Tjeerdsma, M T Meinardi, W T A van der Graaf, M P van den Berg, N H Mulder, H J G M Crijns, E G E de Vries, and D J van Veldhuisen Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables Heart, April 1, 1999; 81(4): 419 - 423. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishise, H. Asanoi, S. Ishizaka, S. Joho, T. Kameyama, K. Umeno, and H. Inoue Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure J Appl Physiol, April 1, 1998; 84(4): 1234 - 1241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Le Guludec, A. Cohen-Solal, J. Delforge, N. Delahaye, A. Syrota, and P. Merlet Increased Myocardial Muscarinic Receptor Density in Idiopathic Dilated Cardiomyopathy : An In Vivo PET Study Circulation, November 18, 1997; 96(10): 3416 - 3422. [Abstract] [Full Text]
|
|
|
|
|
|
P. Ponikowski, T. P. Chua, M. Piepoli, D. Ondusova, K. Webb-Peploe, D. Harrington, S. D. Anker, M. Volterrani, R. Colombo, G. Mazzuero, et al. Augmented Peripheral Chemosensitivity as a Potential Input to Baroreflex Impairment and Autonomic Imbalance in Chronic Heart Failure Circulation, October 21, 1997; 96(8): 2586 - 2594. [Abstract] [Full Text]
|
|